Clinical Trial Update: A Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of PKN605 in Participants With Atrial Fibrillation [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the efficacy, safety, tolerability and pharmacokinetics of PKN605 in participants with atrial fibrillation; the study is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• PKN605

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Atrial Fibrillation | Phase 2 | Status: RECRUITING